Sulforaphane Induces P53-Deficient SW480 Cell Apoptosis Via the ROS-MAPK Signaling Pathway

Hai Lan,Hongyin Yuan,Congyao Lin
DOI: https://doi.org/10.3892/mmr.2017.7558
IF: 3.423
2017-01-01
Molecular Medicine Reports
Abstract:Sulforaphane (SFN) has been revealed to inhibit the growth and induce apoptosis of cancer cells. However, the detailed anticancer effects of SFN on p53-deficient colon cancer cells has yet to be clearly elucidated. The present study employed p53-deficient SW480 cells to establish an SFN-induced in vitro model of apoptosis. The critical events leading to apoptosis were then evaluated in SFN-treated p53-deficient SW480 cells, by performing an MTT assay, flow cytometry, western blotting and ELISA. The results demonstrated that SFN at concentrations of 5, 10, 15 and 20 mu M induced mitochondria-associated cell apoptosis, which was further confirmed by disruption of the mitochondrial membrane potential, an increase in the Bax/Bcl-2 ratio, as well as activation of caspase-3,-7 and -9. In addition, SFN-induced apoptosis was associated with an increase in the generation of reactive oxygen species (ROS), and the activation of extracellular signal-regulated kinases (Erk) and p38 mitogen-activated protein kinases. However, SFN did not induce expression of the p53 family member, p73. SFN-induced apoptosis was subsequently confirmed to be ROS-dependent and associated with Erk/p38, as the specific inhibitors for ROS, phosphorylated (p)-Erk and p-p38, completely or partially attenuated the SFN-induced reduction in SW480 cell viability. In addition, the results demonstrated that even at the lowest concentrations (5 mu M), SFN increased the sensitivity of p53-proficient HCT-116 cells to cisplatin. In conclusion, the results suggest that SFN may induce apoptosis in p53-deficient SW480 cells via p53/p73-independent and ROS-Erk/p38-dependent signaling pathways.
What problem does this paper attempt to address?